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enzymatic assay lor ethylene glycol, however, has not been 
previously documented. The interference may not have been 
appreciated in previous evaluations of the assay because test References 
compounds, such as lactate and alcohols, were added to normal 
serum, not sera from critically ill patients [2]. To evaluate the 
performance oí the enzymatic assays for ethylene glycol and 
ethanol in hospitalized patients with abnormal serum chemistry, 
we added di,-lactic acid to two random serum samples with
markedly increased LD and performed the enzymatic assays
We thank Brian Gilmore for expert technical assistance.
1 ). Lactate ? not interfere in assay;
however, the concomitant presence of LD under the proper
s in
.'es NAD l í ,  resulting in substantial false- 
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ethanol. Given their correlation with the concentrations of LD 
and lactic acid, these false-positive values may be due to the
conversion of serum lactate and reagent NAD + to
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T o  support this hypothesis, we reconstituted normal serum 
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glycol enzymatic assay gave falsely positive results when LD 0031-24-3451346) 
serum  activity was >3000 U/L, as did the ethanol enzymatic
assay when LD serum activity was >2000 U/L (Fig. 1). The According to die recommendations of the National Cholesterol 
interference was most pronounced when the concentration of Education Program Adult Treatment Panel, low-density li- 
UL-lactate exceeded 10 mmol/L. These data, however, should poprotein cholesterol (LDL-chol) should be used for screening
n o t be strictly extrapolated to die clinical setting because the 
contribution to total LD activity in this experiment was due 
solely to LD-5, and the concentration of lactate consisted of 
approximately equal amounts of l- and D-isomers. In hospital­
ized patients, increased LD activity may be due primarily to the
: isoenzyme or of more than onecontribution of a
isoenzyme, and increased lactate concentration will most prob- 
ablv be the L-isomer. However, the data obtained from three
r
hospitalized patients with increased serum LD activity (Table 1) 
support a clinically relevant guideline that significant false-
c results occur when the LD serum activity is at least 
12-fold greater than the tipper limit of the reference interval,
and as a primary treatment criterion for patients with increased 
total cholesterol concentrations [1], This makes the need for 
accurate measurements of LDL-chol a national public health 
imperative. The use of the Friedewald equation is attractive, but 
its accuracy is in doubt in plasma samples with triglyceride (TG) 
concentrations >4.5 mmol/L (400 mg/dL) [2-7], A decennium 
ago we found the Friedewald equation to be accurate up to a T G  
concentration of 8 mmol/L [SJ. Assuming diat similar plasma 
samples were analyzed, these findings raise questions about the 
quality of the methods used in other laboratories, especially in 
the analysis of hypertriglyceridemic samples. The disposal of a 
direct LDL-chol method not interfered with by hypertriglycer­
idemia [9] prompted us to evaluate its accuracy in hyperlipid-
and lactate is concomitantly at least 10-fold greater than the emic samples, including a selection with familial dysbetalipopro
upper limit of its reference interval. teinemia (FD). We hoped that this revaluation could shed more
«n
H igh concentrations of lactate and LD in sera from critically light on our previously reported claim concerning the accuracy
ill patients interfered in the enzymatic assay for ethylene glycol of the Friedewald calculation compared with that of the refer- 
by increasing the production of NADII. Although lactate added
to  normal sera does not interfere with the assay, results should Overnight fasted blood samples from healthy persons and
be interpreted cautiously in samples with high LD and lactate from patients with various types of hyperlipoproteinemia were
concentrations. ( )ther interferences reported for the ethylene 
glycol enzymatic assay include glyceraldehyde and glycerol, 
which can be oxidized by the enzyme glycerol dehydrogenase 
(2j. T h e  enzymatic assay is otherwise very specific, and other 
alcohols—including ethanol, methanol, and isopropanol— do 
not interfere with interpretation. Ethylene glycol poisoning of 
previously healthy individuals may result in lactic acidosis but 
will no t typically result in increased LD. However, this analyt­
ical interference becomes clinically relevant in cases of suspected
ethylene glycol poisoning of individuals with hepatic, renal, oi
cardiac w m ay both lactic acidosis and
drawn into Vacutainer Tubes containing EDTA (Becton Dick­
inson, Meylan Cedex, France). Plasma samples were analyzed 
fresh. If sufficient amounts of plasma were available, two 
uots were stored at -80  °C for >3 months; one was supplied 
with saccharose (final concentration 6 g/L). Patients were 
classified into the different phenotypes according to the criteria 
of Fredrickson et al. [10] with cutoff limits for plasma choles­
terol, TG, and LDL-chol of 6.5, 2.0, and 4.6 mmol/L, respec-
Plasma samples with lipemia, especially those from 
subjects with FD, were preferentially included. This means that 
the frequency of samples with FD was considerably higher than
increased serum LD. Positive results in the enzymatic assay for
m healthy population. 217 fresh plasma samples
i
e e n e )1 in •a.1- 1 with a
different method such as gas chromatography.
analyzed included, by selection, 63 with a plasma T G  concen­
tration >4.5 mmol/L, among which were 31 with a plasma T G  
>8.0 mmol/L; 11 had a VLDL-chol/plasma T G  ratio >0.69
Technical Briefs
(diagnostic tor FD ¡1IJ), The latter subjects were homozygotes automated systems (Boehringer Mannheim cat. no. 759350). 
tor apoprotein E2 [12], Following the stategy of our preceding The accuracy of the procedure was checked against the im- 
s t li civ /iS’/, we classified plasma of subjects with fasting plasma proved Abeil-Kendall procedure and the bias was < 0 .3 % ;
I G concentrations <8 mmol/L as phenotype IV and those >8 imprecision was 1.9% (n = 30). T G  were analyzed on  the
phenotype V hyperlipoproteinemia. Hitachi 747; die accuracy was checked against a semiautomated
the 217 samples analyzed fresh with the ultracentrif- colorimetric method [15]’, imprecision was 1.6% (n = 30) for
ition method and the friedewald formula, 147 fresh samples concentrations up to 12 mmol/L. The accuracy of the IT D L - 
were also av¡.............for analysis with the immunoseparation chol method was confirmed by comparison with sequential
method; U 0 of these samples could be analyzed both fresh and ultracentrifugation and against the polyethylene glycol-6000 
alter freeze-thawing, including 64 to which saccharose (final
r«*i4i uv? il ;d before freezing.
n»
i
I he reference method we used was a combined ultracentrif-
ocedure. VLDL-chol was determined 
directly in the VLDL isolated by sequential ultracentrifugation 
11 ’!• Alter ultracentrifugation of plasma in the T F T  45.6 rotor
ürich, Switzerland) for 16 h at 131 000 g  in the 
an L7-55 ultracentrifuge at 14 °C, the density <1.006 
fraction was aspirated by means of a rubber bulb Pasteur
was determined in plasma after precipitation
of the VLDL and LDL with phosphotungstic acid and MgCl2 
(cat. no. 543004; Boehringer Mannheim, Mannheim, Germa­
ny). LDL-ehol was calculated by subtraction. Reproducibility, 
expressed as the CV, was 4.3% for VLDL-chol determination, 
2.6% for HDL-chol determination, and 2.3% for LDL-chol
I
a lion (n 30).
Sigma
w
reagent was obtained from
LDL-cholesterol, cat. no. 353-A, lot no. 
055H6275; St. Louis, MO). The procedure was performed
manufacturer’s directions. The LDL-chol 
reagent consists of a suspension of polystyrene latex beads
goat polyclonal antibodies to human apoproteins in 
a buffer containing 1 g/L sodium azide, From this reagent 200 
IáL is pipetted into the inner compartment of a separation tube
(fritted microcentrifugation tubes); to the same compartment we
30 jaL  of either the controls (concentrations low and 
included in the kit) or plasma, capped the tubes, and 
vortex-mixed them. After incubation for 5 to 10 min at room 
temperature, we centrifuged the tubes for 10 min at 4300 g at 
room temperature. Subsequently, the filtrate in the outer com­
partment was vortex-mixed and assayed for cholesterol. Al­
though the vortex-mixing step was not mentioned in the pre­
scription of the supplier, it was found to be essential 
obtaining precise results. The 
mined in
precipitation method [16, 17] and un 
The HDL-method used appeared to be very convenient for 
normo- and hyperlipidemic plasma in that veiy few samples had 
to be ultrafiltered to clear turbid supernates.
Results were analyzed by Student’s paired /--test, 
obtained by different methods were correlated by using P ea r­
son’s correlation test with the application of the 
statistical software (version 3.1) (SSPS, 
standard errors in die intercept, slope, and estimate 0S'V^,) w ere 
also calculated by using die test of Passing and Bablock [18J. For 
all intermediod comparisons the deviations in intercept and 
slope did not deviate from die ideal curve y  ~  x. Differences 
were considered significant at P <0.05.
We applied the various methods for determining L D L -cho l 
in 217 fresh plasma samples with T G  concentrations rang ing  
from 0.41 to 50.1 mmol/L including 31 samples with a concen­
tration >8.0 mmol/L and 11 samples of subjects with obligate 
FD with VLDL-chol/TG ratio >0.69. The results obtained 
widi the LDL direct mediod agreed better with the reference 
method than die estimated LDL-chol values (correlation coef­
ficients 0.94 vs 0.85, S^Y values 0.34 vs 0.55, respectively).
However, after exclusion of the samples with plasma TCï > 8 .0  
mmol/L and the samples of the patients with FD (all having a
177)
LDL-direct method (n = 115) (correlation eoeficients
concentration
llltrate was multiplied by 7.35 to obtain the ratio VLDL-chol/plasma T G  in the plasma
I,
1 > v
4 chol concentration in plasma. The precision, as ex 
e interassay CV, was 5.8% and 4.9% for the low- and
VSiconcentration control, respectively (n
i’Vs mentioned before /«V/, the accuracy of the Friedewald
formula (LDL-e f i - ' . total chol I
TG) is influenced by the accuracy of the
ermimuion of cholesterol, TG, and HDL-chol. Further-
relation between the concentration of plasma T G  and'C,
VLDL-chol is dependent on age, sex, and sociodemographic 
variations of the subjects studied [14]. For most accurate results
we
f
a value of 0.42 X T G IÎU
VLDL-chol/plasma TG  ratio >0.69), the results (n 
obtained with the Friedewald equation correlated very well with 
the reference method, similarly as those obtained w ith  the
> 0 .9 7 ,
SV>Y values <0.21, regression equations by Passing and Bablock 
analysis not different from x  = y). These results are in ag ree­
ment with those reported previously [8]. Results obtained for the 
non-FD plasma samples with T G  concentrations between 4  and 
8 mmol/L were explicitly similar to the general mean results 
(data not shown). These findings can be explained by the relative 
constancy
samples with TG  concentrations up to 14 mmol/L (Fig. 1), 
Thus, we did not obtain evidence for a shift in the chemical 
composition data as a result of an excess of chylomicrons at 
increasing plasma T G  values.
In the non-FD samples with TG <8.0 mmol/L in which the 
Friedewald approach gave accurate values, intermethod p rec i­
sions of the Friedewald-ultracentrifugation comparison and  the 
direct L D L -ultracentrifugati on comparison were similar 
0.17 vs 0.21, respectively).
A negative bias o f — 11% was obtained with the direct m ethod  
best approach for (v) after prior storage of the plasma samples at "80  °C com -
« C u U L r i 10).
0.45 X plasma
< 4«
■V LDL-cholesterol pared with the reference method (x): mean .v, 4.12 1.98
Cholesterol was determined (with the reagent of Boehringer mmol/L; mean y, 3.58 ± 1.75 î
samples ct
cat. no. 1489704) on the Hitachi 747 analyzer. For
a micro method was used, in which 20
equation y 0.89* 0.02, correlation coefficient r  «  0.93, Sviv 
0.35, n = 110. Apparently, some of the LDL was retained in 
¡jlL of sample was mixed with 250 juX. of reagent for 10 min. the column. Addition of 6 g of saccharose per liter of plasma 
( )ther conditions were similar to the macro procedure applied before freezing prevented this, as could be derived from  the
for total plasma cholesterol. We used a calibrating serum for statistical results: mean .v, 4.01 ±  1.98 mmol/L; mean y, 3.81 ±
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Fig. 1. Relation between the ratio VLDL-chol/plasma TG and the 
plasma TG concentration.
1.87 mmol/L, P = 0.12; linear regression equation y  = 0.99a: — 
0.01, r =  0.92, 5^, = 0.22, n = 64.
In the present study we confirm our earlier findings [8] that 
estimated LDL-chol by the Friedewald formula is not only 
accurate in plasma samples with TG  concentrations <4.5 
mmol/L, but also in samples with TG  concentrations between 
4.5 and 8 mmol/L, at least when the seldom-occurring samples 
with FD (prevalence ~0 .1-0.5% in the healthy population) are 
excluded. With the latter samples a positive bias is obtained [8] 
that expresses die additional coronary heart disease risk due to 
the contribution of VLDL remnants.
Up to a TG  concentration of 8 mmol/L the Friedewald 
approach and the direct LDL method gave similar scores both 
for accuracy and precision, stressing the validity of our experi­
ments in general and the accuracy of our reference method 
especially. The greater applicability of the Friedewald calcula­
tion in our hands could be due to the fact that we analyzed fasted 
plasma samples. Chylomicrons present in nonfasting plasma are 
thought to result in too low LDL-chol values because VLDL- 
chol in these samples is overestimated when using 0.45 X plasma 
T G  (in mmol/L) as an approach. However, even in the non-FD 
samples with a plasma T G  concentration of 8 to 14 mmol/L, 
characterized by increased concentrations of chylomicrons, sta­
tistical analysis revealed that the intercept of the curve depicting 
die relation between die estimated and determined LDL-chol vs 
die reference value did not differ from 1.0 (Passing and Bablock 
analysis, data not shown). This cast doubts on die suggestion 
that die analysis of fasting plasma samples in our study merely 
explains the difference in the applicability of the Friedewald 
formula compared with odier laboratories. This is also sup­
ported by die relatively constant estimate for VLDL-chol that 
we observed, independent of die plasma TG  concentration. Our 
observations suggest that in other laboratories one of the 
analytical mediods delivering values for substitution in die 
Friedewald formula is biased or imprecise, especially when 
hypertriglyceridemic plasma samples are analyzed. This is sup­
ported by the results of McNamara et al. [2]: At TG  concentra­
tions >4.00 g/L (4.5 mmol/L), large standard deviations prevent 
the drawing of conclusions concerning the optimal estimation
•  % # •  *  
•  . t  %  •
V  v W  .A i
ft
«
t
«
♦♦
• •
factor (TG/4.5 to TG/8) as an approach for VLDL-chol, in 
contrast to our results. We can only speculate which of the 
methods is responsible for the reported large variation of the 
bias between estimated and measured LDL-chol values. It is 
generally known that HDL-chol analysis in hypertriglyceride­
mic plasma samples is potentially biased because of possible 
incomplete removal of the apo B-containing lipoproteins [19J. 
Theoretically, also, the method for the determination of TG  
may be biased in hypertriglyceridemic samples. Standardization 
on the basis of the CDC protocol does not exclude this, because 
only normo- or slighdy hyperlipidemic controls have to be 
analyzed in this program. Because of the lack of suitable control 
material, the quality of the analyses at higher degrees of lipemia 
is at present uncertain. This is more true in methods requiring 
lipemic samples to be severalfold diluted for proper calibration. 
It is also possible, as already suggested by Friedewald et al. [20], 
that the reference method is biased or imprecise when hyper­
triglyceridemic plasma samples are analyzed. To prevent this we 
determined VLDL-chol direcdy, whereas most other laborato­
ries determine VLDL-chol indirecdy as the difference of total 
cholesterol and the cholesterol present in the d >1.006 kg/L 
fraction. The latter procedure can result in highly variable 
VLDL-chol concentrations involving imprecise cholesterol 
analysis. In the same way, relatively large CVs of the methods 
used in these evaluations overestimate the bias in LDL-chol of 
the Friedewald approach, especially for lipemic plasma. In 
plasma samples with TG >8.0 mmol/L the direct method is 
preferred over the Friedewald approach. Until now, large-scale 
use of the direct method is prevented by the instability of the 
analyte when stored frozen [20]. Irrespective of the value of any 
method in the risk estimation for coronary heart disease, the 
support of a lipid reference laboratory remains necessary be­
cause of the limited value of both the Friedewald approach and 
the direct LDL-method for proper phenotyping of strongly 
hyperlipidemic samples. Considering the fact that the measured 
plasma triglyceride concentration also gives insight into the 
LDL subfraction pattern [21, 22] and in the presence of dense 
LDL, reportedly being associated with increased atherogenesis 
[23, 24], the use of the Friedewald formula is recommended up 
to a TG  concentration of 8 mmol/L.
We thank Sigma Diagnostics for providing the reagents of the 
immunoseparation kit.
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A characteristic rise and fall in the concentrations of creatine uncommonly encountered in the evaluation of ischemic heart
kinase (CK) and its MB isoenzyme are often used as indicators disease. The patients studied were 42 women and 10 men. TSH
of myocardial damage ///. However, CK may be abnormally values ranged from 25.1 to 295.5 mU/L (mean 79.7). Free
This thyroxine (iT4) values ranged from undetectable to 12.9 pmol/L
MB
[2]
to increase in
(reference range 10.3-23.2 pmol/L). The same sample used to 
measure T SH  and 1T4 was also used to measure CK, CK-MB,
patients without apparent myocardial damage [3]. Hypothyroid cholesterol, and cardiac TN -I. TSH  and f f 4 were measm 
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